A real-world international observational study of mogamulizumab in adult patients with mycosis fungoides and Sezary syndrome (PROSPER study NCT05455931)
Authors
Scarisbrick, JWilliams, A
Ardigò, M
Arumainathan, A
Cowan, Richard
DeSimone, J
Geskin, L
Goldaniga, M
Hashmi, S
James, E
Musiek, A
Muniesa, C
Nassi, L
Pileri, A
Vallverdu, RP
Quint, K
Rozati, S
Rupoli, S
Shinohara, M
Pagano, L
Affiliation
The Christie NHS Foundation Trust, The Christie NHS Foundation Trust, Manchester, United KingdomIssue Date
2023
Metadata
Show full item recordCitation
Scarisbrick J, Williams A, Ardigò M, Arumainathan A, Cowan R, DeSimone J, et al. A real-world international observational study of mogamulizumab in adult patients with mycosis fungoides and Sezary syndrome (PROSPER study NCT05455931). EUROPEAN JOURNAL OF CANCER. 2023 SEP;190:S32-S3. PubMed PMID: WOS:001077487800074. English.Journal
European Journal Of CancerDOI
10.1016/j.ejca.2023.113061Additional Links
https://dx.doi.org/10.1016/j.ejca.2023.113061Type
PresentationLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.ejca.2023.113061